These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 22343072
21. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice. Ding L, Meng Y, Zhang HY, Yin WC, Yan Y, Cao YP. Neurosci Lett; 2016 Nov 10; 634():1-6. PubMed ID: 27693663 [Abstract] [Full Text] [Related]
22. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA. J Neurosci; 2010 Jun 16; 30(24):8180-9. PubMed ID: 20554868 [Abstract] [Full Text] [Related]
23. Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice. Janssens J, Hermans B, Vandermeeren M, Barale-Thomas E, Borgers M, Willems R, Meulders G, Wintmolders C, Van den Bulck D, Bottelbergs A, Ver Donck L, Larsen P, Moechars D, Edwards W, Mercken M, Van Broeck B. Neurobiol Dis; 2021 Jul 16; 154():105365. PubMed ID: 33848635 [Abstract] [Full Text] [Related]
24. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain. Wu G, Miller RA, Connolly B, Marcus J, Renger J, Savage MJ. Neurodegener Dis; 2014 Jul 16; 14(2):53-66. PubMed ID: 24158021 [Abstract] [Full Text] [Related]
25. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL, Tung YC, Liu F, Gong CX, Iqbal K. Alzheimers Res Ther; 2017 Jan 10; 9(1):1. PubMed ID: 28073379 [Abstract] [Full Text] [Related]
26. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T. Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551 [Abstract] [Full Text] [Related]
27. Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy. Wang A, Das P, Switzer RC, Golde TE, Jankowsky JL. J Neurosci; 2011 Mar 16; 31(11):4124-36. PubMed ID: 21411653 [Abstract] [Full Text] [Related]
28. Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1ΔE9 Transgenic Mice. Sivasaravanaparan M, Olesen LØ, Severino M, von Linstow CU, Lambertsen KL, Gramsbergen JB, Hasselstrøm J, Metaxas A, Wiborg O, Finsen B. J Alzheimers Dis; 2022 Mar 16; 87(2):685-699. PubMed ID: 35342093 [Abstract] [Full Text] [Related]
29. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. Maier M, Seabrook TJ, Lazo ND, Jiang L, Das P, Janus C, Lemere CA. J Neurosci; 2006 May 03; 26(18):4717-28. PubMed ID: 16672644 [Abstract] [Full Text] [Related]
31. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS. J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767 [Abstract] [Full Text] [Related]
32. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease. Minami SS, Sidahmed E, Aid S, Shimoji M, Niikura T, Mocchetti I, Rebeck GW, Prendergast JS, Dealwis C, Wetzel R, Bosetti F, Matsuoka Y, Hoe HS, Turner RS. J Neuroinflammation; 2010 Sep 28; 7():57. PubMed ID: 20920207 [Abstract] [Full Text] [Related]
33. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells. Sun T, Shi Q, Zhang Y, Power C, Hoesch C, Antonelli S, Schroeder MK, Caldarone BJ, Taudte N, Schenk M, Hettmann T, Schilling S, McDannold NJ, Lemere CA. J Control Release; 2021 Aug 10; 336():443-456. PubMed ID: 34186148 [Abstract] [Full Text] [Related]
35. N-truncated Aβ4-x peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse models. Wirths O, Walter S, Kraus I, Klafki HW, Stazi M, Oberstein TJ, Ghiso J, Wiltfang J, Bayer TA, Weggen S. Alzheimers Res Ther; 2017 Oct 04; 9(1):80. PubMed ID: 28978359 [Abstract] [Full Text] [Related]
36. A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice. Demattos RB, Lu J, Tang Y, Racke MM, Delong CA, Tzaferis JA, Hole JT, Forster BM, McDonnell PC, Liu F, Kinley RD, Jordan WH, Hutton ML. Neuron; 2012 Dec 06; 76(5):908-20. PubMed ID: 23217740 [Abstract] [Full Text] [Related]
37. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, Sullivan PM, Holtzman DM. Acta Neuropathol Commun; 2015 Nov 10; 3():70. PubMed ID: 26556230 [Abstract] [Full Text] [Related]
38. Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization. Marjańska M, Weigand SD, Preboske G, Wengenack TM, Chamberlain R, Curran GL, Poduslo JF, Garwood M, Kobayashi D, Lin JC, Jack CR. Neuroscience; 2014 Feb 14; 259():94-100. PubMed ID: 24316473 [Abstract] [Full Text] [Related]
39. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage. Nikolic WV, Bai Y, Obregon D, Hou H, Mori T, Zeng J, Ehrhart J, Shytle RD, Giunta B, Morgan D, Town T, Tan J. Proc Natl Acad Sci U S A; 2007 Feb 13; 104(7):2507-12. PubMed ID: 17264212 [Abstract] [Full Text] [Related]
40. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY, Kim YS, Lee J, Mook-Jung I. J Alzheimers Dis; 2012 Feb 13; 29(3):615-28. PubMed ID: 22269161 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]